MNM selection, acquisition, engineering, characterisation (WP2)

April 2014: Surface engineering of fluorescent silica nanoparticles for biolabelling applications. NanoTox 2014, Antalya. Isaac Ojea-Jiménez, Matteo Pedroni, Dora Mehn, Sabrina Gioria, Douglas Gilliland, François Rossi, JRC - Institute for Health and Consumer Protection (IHCP), IT.

April 2014: High–Throughput–Screening-Fluorescence–Correlation–Spectroscopy for Protein Corona Binding Studies. NanoTox 2014, Antalya. Tobias Preiß, Silvia Milani, Judith Mittag, Joachim Rädler. Ludwig-Maximilians-Universität (Munich).

Development of a screening platform for MNMs (WP4)

April 2014: Developing in vitro and in vivo high throughput screening platforms for hazard prediction of manufactured nanomaterials. NanoTox 2014, Antalya. Katrin Volkmann, Iris Hansjosten, Juliane Rapp, Iseult Lynch, Eugenia  Valsami Jones, Silvia Diabaté, Carsten Weiss. Karlsruhe Institute of Technology, DE;  University of Birmingham,  UK. MNM interactions with biomolecules and environmental factors (WP5)

April 2014: Nanoparticle Tracking Analysis (NTA) for Time-resolved, reproducible Nanoparticle Characterisation under Environmentally Relevant Conditions. NanoTox 2014, Antalya. Phil Vincent, Ian Wilson, Patrick Hole. NanoSight Ltd, UK.

April 2014: Development of Adverse Outcome Pathways as a tool for understanding and analysis of nanoparticle-induced liver toxicity. NanoTox 2014, Antalya. Kirsten Gerloff, Taina Palosaari, Brigitte Landesmann, Maurice Whelan. Joint Research Centre, It.

April 2014: Kinetic Studies of Apoptosis on Single Cell Arrays in High-Througput. NanoTox 2014, Antalya. P. J. F. Röttgermann and J. O. Rädler. Ludwig-Maximilians-Universität (Munich, De).

MNM interactions with biomolecules and environmental factors (WP5)

June 2016: Cell based biosensor approach  to characterize  interactions between nanoparticles and cell surface receptors. Attana (QCM) biosensor networking meeting, London. Diluka Peiris, Daniel Wallinder, Teodor Aastrup, Attana AB (Sw), David Garry, UCD (Ir).

MNM bioavailability and biological effects in vitro/in vivo (ecotoxicology) (WP6)

April 2014: Developing a Maternal Transfer Model for Nanomaterials in a Novel Fish System. NanoTox 2014, Antalya. Rhys M. Goodhead, Victoria Jennings, Simone Tinguely, Charles R.Tyler. U. of EXETER, UK & University of Applied Sciences North-western Switzerland, CH.

April 2014: Nanoparticle-bio-interactions in the soil nematode Caenorhabditis elegans: Silica nanoparticles induce premature aging phenotypes. NanoTox 2014, Antalya. Annette Piechulek, Andrea Scharf and Anna von Mikecz. IUF - Leibniz Research Institute of Environmental Medicine, DE. 

MNM biokinetics and toxicity testing in vitro/in vivo (human toxicology) (WP7)

Feb. 2017: The influence of redox activity of inhaled nano-sized cerium dioxide on respiratory, immune and cardiovascular effects in multiple mouse models. NMSA Malaga, Susan Dekkers1, Mark Miller2, Roel Schins3, Rob Vandebriel1, Isabella Römer4, Mike Russ5, Marie-France Belinga-Desaunay-Nault4, Shea Connell2, Ian Smith2, Paul Fokkens1, John Boere1, Daan Leseman1, Jolanda Vermeulen1, Eric Gremmer1, Liset de la Fonteyne1, Harm Heusinkveld1,3, Catrin Albrecht3, Tina Wahle3, Adriana Sofranko3, Christine Soputan6, Wim de Jong1, Flemming Cassee1,6,. RIVM, The Netherlands, 2 University of Edinburgh, United Kingdom, 3 IUF, Germany, 4 University of Birmingham, United Kingdom, 5 Promethean Particles Ltd, United Kingdom, 6 Institute for Translational Vaccinology (Intravacc), The Netherlands, 7 University of Utrecht, The Netherlands. RSC Environmental Science: Nano best poster Prize at the NMSA Malaga conference

Sept. 2015: Implications of redox activity of CeO2 nanoparticles for immunological responses in vitro.  EUROTOX2015. Susan Dekkers1, Jolanda P. Vermeulen1, Geert van der Horst1, Rory Verhagen1, Isabella Römer2, Mike Russ3, Flemming R. Cassee1,4, Wim H. De Jong1, Rob J. Vandebriel1. 1 RIVM, Bilthoven, The Netherlands; 2 University of Birmingham, Birmingham, United Kingdom; 3 Promethean Particles Ltd, Nottingham, United Kingdom; 4 Utrecht University, Utrecht, The Netherlands

May 2015 - A lab scale measurement technique for the air-liquid interface exposure of human lung cell cultures towards airborne nanoparticlesMülhopt, S, Diabate, S, Schlager, C., Dilger, M., Weiss, C., Karlsruhe Institute of Technology (De); Krebs, T., Vitrocell Systems GmbH (De). 20th International Congress on Aerosols in Medicine and Pulmonary Drug Delivery  (ISAM 2015), München - Journal of Aerosol Medicine and Pulmonary Drug Delivery, 28 (2015) No.3, A30.

April 2014: Inflammasome Activation by Nanomaterials. NanoTox 2014, Antalya. Susan Dekkers, Elmer Harms, Jolanda P. Vermeulen, Flemming R. Cassee, Wim H. De Jong, Rob J. Vandebriel. RIVM, NL.

April 2014: Pulmonary effects and biokinetics of nanoparticles: Whole-body inhalation exposure to CeO2 in 5-day, 28-day and 90-day rat studies. NanoTox 2014, Antalya. J.Keller, K.Küttler, L. Ma-Hock, V. Strauss, S. Gröters, K. Wiench, B. van Ravenzwaay and R. Landsiedel. BASF, DE.

Data integration, QPARs, risk assessment, safe MNM designs (WP9)

Sept. 2014: Computer aided nanoparticles design through Enalos InSilicoNano Platform. OpenTox Euro 2014. Georgia Melagraki and Antreas Afantitis, Novamechanics (Cyprus).

April 2014: A strategy for grouping of nanomaterials based on key physico-chemical descriptors as a basis for safer-by-design NMs. NanoTox 2014, Antalya. Iseult Lynch, Carsten Weiss and Eugenia Valsami-Jones. University of Birmingham, UK; Karlsruhe Institute of Technology, DE.

Dissemination, exploitation, integration (WP10)

June 2015: Interest & impacts of NanoMILE for industry and service providers. EuroNanoForum 2015. B. Hazebrouck, EU-VRi (Germany), I. lynch , University of Birmingham, UK.